These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3610213)

  • 1. Cyclosporin A inhibits mitogen-activated but not phorbol ester-activated locomotion of human lymphocytes.
    Wilkinson PC; Higgins A
    Immunology; 1987 Jul; 61(3):311-6. PubMed ID: 3610213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FK506 and pertussis toxin distinguish growth-induced locomotor activation from attractant-stimulated locomotion in human blood lymphocytes.
    Wilkinson PC; Watson EA
    Immunology; 1990 Nov; 71(3):417-22. PubMed ID: 1702750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The defect of lymphocyte locomotion in chronic lymphocytic leukaemia: studies of polarization and growth-dependent locomotion.
    Wilkinson PC; Islam LN; Sinclair D; Dagg JH
    Clin Exp Immunol; 1988 Mar; 71(3):497-501. PubMed ID: 3383451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The locomotor capacity of human lymphocytes and its enhancement by cell growth.
    Wilkinson PC
    Immunology; 1986 Feb; 57(2):281-9. PubMed ID: 3081438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OKT3-activated locomotion of human blood lymphocytes: a phenomenon requiring contact of T cells with Fc receptor-bearing cells.
    Wilkinson PC; Higgins A
    Immunology; 1987 Mar; 60(3):445-51. PubMed ID: 3494670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration with phorbol ester of a locomotor defect in human leukaemic lymphocytes: a visual study of chronic lymphocytic leukaemia cells.
    Islam LN; Wilkinson PC
    Invasion Metastasis; 1992; 12(1):47-56. PubMed ID: 1380953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the inhibition by glucocorticosteroids and cyclosporin A of mitogen-stimulated human lymphocyte proliferation.
    Gordon D; Nouri AM
    Clin Exp Immunol; 1981 May; 44(2):287-94. PubMed ID: 7307337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte locomotion "in vitro": the role of growth activators and chemoattractants.
    Wilkinson PC
    Biomed Pharmacother; 1987; 41(6):329-36. PubMed ID: 3328629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant IL-4 and IFN-gamma activate locomotor capacity in human B lymphocytes.
    Wilkinson PC; Islam LN
    Immunology; 1989 Jun; 67(2):237-43. PubMed ID: 2502496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locomotor responses of human CD45 lymphocyte subsets: preferential locomotion of CD45RO+ lymphocytes in response to attractants and mitogens.
    Newman I; Wilkinson PC
    Immunology; 1993 Jan; 78(1):92-8. PubMed ID: 8436407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte activation by OKT3: cyclosporine sensitivity and synergism with phorbol ester.
    Kay JE; Benzie CR
    Immunology; 1986 Feb; 57(2):195-9. PubMed ID: 3485075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.
    Miyawaki T; Yachie A; Ohzeki S; Nagaoki T; Taniguchi N
    J Immunol; 1983 Jun; 130(6):2737-42. PubMed ID: 6406595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of phorbol myristate acetate and phytohaemagglutinin as stimulators of in vitro T lymphocyte colony formation of human peripheral blood lymphocytes. I. Surface markers of colony cells.
    Suzawa T; Hyodo S; Kishi T; Kashiwa H; Karakawa T; Kittaka E; Sakano T; Usui T
    Immunology; 1984 Nov; 53(3):499-505. PubMed ID: 6333386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoattractant activity of IL-2 for human lymphocytes: a requirement for the IL-2 receptor beta-chain.
    Wilkinson PC; Newman I
    Immunology; 1994 May; 82(1):134-9. PubMed ID: 8045589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cyclosporin A on the metabolism of unstimulated and mitogen-activated lymphocytes.
    Kay JE; Benzie CR
    Immunology; 1983 May; 49(1):153-60. PubMed ID: 6840802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin-A and the OKT3 monoclonal antibody exert their respective inhibitory and mitogenic activity on T cells by interacting with the same receptors.
    Palacios R
    J Clin Immunol; 1982 Jul; 2(3 Suppl):15S-19S. PubMed ID: 6982278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling.
    Ranjan D; Chen C; Johnston TD; Jeon H; Nagabhushan M
    J Surg Res; 2004 Oct; 121(2):171-7. PubMed ID: 15501456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of catalase on the proliferation of human lymphocytes to phorbol myristate acetate.
    Sagone AL; Husney R; Guter H; Clark L
    J Immunol; 1984 Sep; 133(3):1488-94. PubMed ID: 6747295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between locomotion, chemotaxis and clustering of immune cells.
    Wilkinson PC
    Immunology; 1990 Jan; 69(1):127-33. PubMed ID: 2138123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
    Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
    Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.